Nature Communications (Sep 2023)

SRC and TKS5 mediated podosome formation in fibroblasts promotes extracellular matrix invasion and pulmonary fibrosis

  • Ilianna Barbayianni,
  • Paraskevi Kanellopoulou,
  • Dionysios Fanidis,
  • Dimitris Nastos,
  • Eleftheria-Dimitra Ntouskou,
  • Apostolos Galaris,
  • Vaggelis Harokopos,
  • Pantelis Hatzis,
  • Eliza Tsitoura,
  • Robert Homer,
  • Naftali Kaminski,
  • Katerina M. Antoniou,
  • Bruno Crestani,
  • Argyrios Tzouvelekis,
  • Vassilis Aidinis

DOI
https://doi.org/10.1038/s41467-023-41614-x
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 20

Abstract

Read online

Abstract The activation and accumulation of lung fibroblasts resulting in aberrant deposition of extracellular matrix components, is a pathogenic hallmark of Idiopathic Pulmonary Fibrosis, a lethal and incurable disease. In this report, increased expression of TKS5, a scaffold protein essential for the formation of podosomes, was detected in the lung tissue of Idiopathic Pulmonary Fibrosis patients and bleomycin-treated mice. Τhe profibrotic milieu is found to induce TKS5 expression and the formation of prominent podosome rosettes in lung fibroblasts, that are retained ex vivo, culminating in increased extracellular matrix invasion. Tks5 +/- mice are found resistant to bleomycin-induced pulmonary fibrosis, largely attributed to diminished podosome formation in fibroblasts and decreased extracellular matrix invasion. As computationally predicted, inhibition of src kinase is shown to potently attenuate podosome formation in lung fibroblasts and extracellular matrix invasion, and bleomycin-induced pulmonary fibrosis, suggesting pharmacological targeting of podosomes as a very promising therapeutic option in pulmonary fibrosis.